VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 422.8 USD | +0.90% |
|
+5.41% | +3.91% |
| May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
| May. 07 | FOMO is Back |  |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.67% | 0 M€ | 0.00% | - | |
| 7.08% | 0 M€ | 0.00% | - | |
| 5.20% | 2 M€ | -.--% | ||
| 4.81% | 7 M€ | -.--% | - | |
| 4.05% | 0 M€ | +8.40% | - | |
| 3.53% | 0 M€ | -2.17% | - | |
| 2.32% | 0 M€ | +9.27% | ||
| 2.28% | 0 M€ | +4.88% | ||
| 1.99% | 12 M€ | +15.09% | - | |
| 1.93% | 0 M€ | 0.00% | - | |
| 1.71% | 2 M€ | -25.75% | ||
| 1.63% | 0 M€ | +7.69% | - | |
| 1.61% | 0 M€ | +8.06% | ||
| 1.58% | 9 M€ | -4.31% | - | |
| 1.10% | 204 M€ | +10.54% | ||
| 1.06% | 0 M€ | +2.39% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.82% | 3 M€ | +15.16% | - | |
| 0.82% | 4 M€ | -.--% | - | |
| 0.82% | 13 M€ | -.--% | - | |
| 0.81% | 26 M€ | +16.85% | - | |
| 0.73% | 0 M€ | 0.00% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.68% | 0 M€ | 0.00% | - | |
| 0.51% | 0 M€ | +8.33% |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
422.8
USD
Average target price
462.1
USD
Spread / Average Target
+9.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B | |
| +295.70% | 8.12B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
